[Federal Register Volume 59, Number 58 (Friday, March 25, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-7029]


[[Page Unknown]]

[Federal Register: March 25, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

National Heart, Lung, and Blood Institute; Meeting

    Pursuant to Public Law 92-463, notice is hereby given of the 
meeting of the following Heart, Lung, and Blood Special Emphasis Panel.
    The meeting will be closed in accordance with the provisions set 
forth in sec. 552b(c)(4) and 552b(c)(6), title 5, U.S.C. and sec. 10(d) 
of Public Law 92-463, for the review, discussion and evaluation of 
individual grant applications, contract proposals, and/or cooperative 
agreements. These applications and/or proposals and the discussions 
could reveal confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the applications and/or proposals, the disclosure of 
which would constitute a clearly unwarranted invasion of personal 
privacy.

Name of Panel: NHLBI SEP on Genetically Enhanced Cardiovascular 
Implants.
Date of Meeting: April 11, 1994.
Time of Meeting: 9 a.m.
Place of Meeting: Holiday Inn, Bethesda, Maryland.
Agenda: To evaluate and review grant applications.
Contact Person: Carl A. Ohata, Ph.D., 5333 Westbard Avenue, room 5A09, 
Bethesda, Maryland 20892, (301) 594-7483.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health)

    Dated: March 18, 1994.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 94-7029 Filed 3-24-94; 8:45 am]
BILLING CODE 4140-01-M